Indicated for use in combination with other medicinal products for the treatment of chronic Hepatitis C (CHC) in adults: 🦠 Genotypes 1–4: Effective across multiple viral genotypes. 🏥 Liver Condition: Suitable for patients with compensated cirrhosis. 🛡️ Co-infection: Safe for patients co-infected with HIV.

Dosage and administration

Packaging: 60 mg film-coated tablets. ⚠️ ADMINISTRATION PROTOCOL (Combination Therapy Only): 💊 Dose: One tablet (60 mg) taken orally once daily. 🕒 Consistency: Take at the same time every day to maintain viral suppression. 🍲 With/Without Food: Can be taken with or without food. Swallow whole. 📅 Duration: Typically 12 weeks. Can be extended to 24 weeks for difficult-to-treat cases (e.g., decompensated cirrhosis).

Monotherapy: Do not take alone; must be combined with Sofosbuvir. Hypersensitivity to the active substance. Pregnancy and breastfeeding. Co-administration with strong inducers of cytochrome P450 3A4 (e.g., St. John’s wort, rifampicin, carbamazepine, phenytoin).

When used with Sofosbuvir, the regimen is generally well-tolerated. Common side effects include: 🤯 Neurological: Headache, dizziness. 💤 General: Fatigue, lassitude. 🤢 Gastrointestinal: Nausea. ⚠️ Drug Interaction: Serious bradycardia may occur if taken with Amiodarone.

Daclaxen — Daclatasvir 60 mg, 28 pcs, Everest

100% original product

Active ingredient

Daclatasvir

Manufacturer

Everest

Dosage 60 mg

Dosage form Tablets

Tablets per pack 28

Daclaxen (Daclatasvir) Tablets

Name: Daclaxen
Brand: Everest
SKU: PROD-129
Price: 1670 UAH
Availability: InStock

1670₴ ~~1846₴~~ -10%

Daclaxen 60 mg (Daclatasvir) is a highly effective NS5A inhibitor (Direct-Acting Antiviral) used to treat Hepatitis C.

Manufacturer: Everest Pharmaceuticals. Each pack contains 28 tablets. It works by targeting the NS5A protein, which is essential for the replication and assembly of the Hepatitis C virus (HCV).

Crucial Information:

Daclatasvir must never be used alone. It is always prescribed in combination with Sofosbuvir. This dual therapy stops the virus at multiple stages of its lifecycle.

✅ Benefit: High cure rates (SVR) across genotypes 1, 2, 3, and 4, even in patients with cirrhosis.

Indicated for use in combination with other medicinal products for the treatment of chronic Hepatitis C (CHC) in adults:

🦠 Genotypes 1–4: Effective across multiple viral genotypes.
🏥 Liver Condition: Suitable for patients with compensated cirrhosis.
🛡️ Co-infection: Safe for patients co-infected with HIV.

Packaging: 60 mg film-coated tablets.

⚠️ ADMINISTRATION PROTOCOL (Combination Therapy Only):

💊 Dose: One tablet (60 mg) taken orally once daily.
🕒 Consistency: Take at the same time every day to maintain viral suppression.
🍲 With/Without Food: Can be taken with or without food. Swallow whole.
📅 Duration: Typically 12 weeks. Can be extended to 24 weeks for difficult-to-treat cases (e.g., decompensated cirrhosis).

Monotherapy: Do not take alone; must be combined with Sofosbuvir.
Hypersensitivity to the active substance.
Pregnancy and breastfeeding.
Co-administration with strong inducers of cytochrome P450 3A4 (e.g., St. John’s wort, rifampicin, carbamazepine, phenytoin).

When used with Sofosbuvir, the regimen is generally well-tolerated. Common side effects include:

🤯 Neurological: Headache, dizziness.
💤 General: Fatigue, lassitude.
🤢 Gastrointestinal: Nausea.
⚠️ Drug Interaction: Serious bradycardia may occur if taken with Amiodarone.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 13.03.2026